Aclaris Therapeutics (ACRS) Inventory Average (2018 - 2019)

Aclaris Therapeutics' (ACRS) quarterly Inventory Average came in at $187000.0 in Q3 2019, down 81.93% year-on-year from $1.0 million in Q3 2018, and down 64.07% quarter-over-quarter from $520500.0 in Q2 2019.

Aclaris Therapeutics (ACRS) Inventory Average (2018 - 2019) Analysis & Trends

Aclaris Therapeutics' Inventory Average history runs 2 years deep, the most recent figure standing at $187000.0 for Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 644.91 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.73 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.15 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Aclaris Therapeutics 705.88 Mn 705.88 Mn 1.60 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 187,000.00
Jun 30, 2019 520,500.00
Mar 31, 2019 823,500.00
Dec 31, 2018 917,500.00
Sep 30, 2018 1.04 Mn